메뉴 건너뛰기




Volumn 39, Issue 1, 1999, Pages 33-37

CYP2D6 HhaI genotype and the neuroleptic malignant syndrome

Author keywords

CYP2D6; Multisystem atrophy; Neuroleptic malignant syndrome; Neuroleptics; Parkinson's disease; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MYELOOPTIC NEUROPATHY; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SHY DRAGER SYNDROME;

EID: 0032945420     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026557     Document Type: Article
Times cited : (15)

References (17)
  • 1
    • 0019458108 scopus 로고
    • Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs
    • Toru M, Matsuda O, Makiguchi K, Sugano K: Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J Nerv Ment Dis 1981;169:324-327.
    • (1981) J Nerv Ment Dis , vol.169 , pp. 324-327
    • Toru, M.1    Matsuda, O.2    Makiguchi, K.3    Sugano, K.4
  • 2
    • 0018638316 scopus 로고
    • Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents
    • Clark WG: Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents. Neurosci Biobehav Rev 1979;3:179-231.
    • (1979) Neurosci Biobehav Rev , vol.3 , pp. 179-231
    • Clark, W.G.1
  • 4
    • 0023754383 scopus 로고
    • Xenobiotic and endobiotic inhibitions of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism
    • Fonne-Pfister R, Meyer UA: Xenobiotic and endobiotic inhibitions of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol 1988;37:3829-3835.
    • (1988) Biochem Pharmacol , vol.37 , pp. 3829-3835
    • Fonne-Pfister, R.1    Meyer, U.A.2
  • 5
    • 0024993985 scopus 로고
    • Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes
    • Yoshida M, Niwa T, Nagatsu T: Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes. Neurosci Lett 1992;119: 109-113.
    • (1992) Neurosci Lett , vol.119 , pp. 109-113
    • Yoshida, M.1    Niwa, T.2    Nagatsu, T.3
  • 6
    • 0025136874 scopus 로고
    • Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible Parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer
    • Ohta S, Tachikawa O, Makino Y, Tasaki Y, Hirobe M: Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible Parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer. Life Sci 1990;46:599-605.
    • (1990) Life Sci , vol.46 , pp. 599-605
    • Ohta, S.1    Tachikawa, O.2    Makino, Y.3    Tasaki, Y.4    Hirobe, M.5
  • 7
    • 0022408175 scopus 로고
    • Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine
    • Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J: Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine. Lancet 1985; ii:1213-1216.
    • (1985) Lancet , vol.2 , pp. 1213-1216
    • Barbeau, A.1    Cloutier, T.2    Roy, M.3    Plasse, L.4    Paris, S.5    Poirier, J.6
  • 9
    • 0027276869 scopus 로고
    • Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans
    • Evans W, Relling M, Rahman A, McLeod H, Scott E, Lin J: Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans. J Clin Invest 1993;91:2150-2154.
    • (1993) J Clin Invest , vol.91 , pp. 2150-2154
    • Evans, W.1    Relling, M.2    Rahman, A.3    McLeod, H.4    Scott, E.5    Lin, J.6
  • 12
    • 0022370639 scopus 로고
    • Neuroleptic malignant syndrome
    • Levenson JL: Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-1145.
    • (1985) Am J Psychiatry , vol.142 , pp. 1137-1145
    • Levenson, J.L.1
  • 13
    • 0026662792 scopus 로고
    • Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYRI) gene in individuals with malignant hyperthermia
    • Gillard EF, Otsu K, Fujii J, Duff C, De Leon S, Khanna VK, Bntt BA, Worton RG, MacLennan DH: Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYRI) gene in individuals with malignant hyperthermia. Genomics 1992; 13:1247-1254.
    • (1992) Genomics , vol.13 , pp. 1247-1254
    • Gillard, E.F.1    Otsu, K.2    Fujii, J.3    Duff, C.4    De Leon, S.5    Khanna, V.K.6    Bntt, B.A.7    Worton, R.G.8    MacLennan, D.H.9
  • 14
    • 0030597048 scopus 로고    scopus 로고
    • Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA
    • Miyatake R, Furukawa A, Matsushita M, Iwahashi K, Nakamura K, Ichikawa Y, Suwaki H: Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA. FEBS Lett 1996;395:123-126.
    • (1996) FEBS Lett , vol.395 , pp. 123-126
    • Miyatake, R.1    Furukawa, A.2    Matsushita, M.3    Iwahashi, K.4    Nakamura, K.5    Ichikawa, Y.6    Suwaki, H.7
  • 15
    • 0026519363 scopus 로고
    • Debriso quine 4-monooxygenase and bufuralol 1-monooxygenase activities in bovine and rabbit tissues
    • Matsuo Y, Iwahashi K, Ichikawa Y: Debriso quine 4-monooxygenase and bufuralol 1-monooxygenase activities in bovine and rabbit tissues. Biochem Pharmacol 1992;43:1911-1919.
    • (1992) Biochem Pharmacol , vol.43 , pp. 1911-1919
    • Matsuo, Y.1    Iwahashi, K.2    Ichikawa, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.